| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2873648 | The Annals of Thoracic Surgery | 2013 | 7 Pages |
Abstract
Intravenous 30 mg/kg methylprednisolone administered before cardiopulmonary bypass resulted in high effective plasma drug concentrations and a decreased inflammatory response. However, no cardioprotective effect or better clinical outcome was noticed.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Juho MD, Eero MD, PhD, Klaus T. MD, PhD, Kaija MD, PhD, Pertti J. MD, PhD, Netta MD, Heikki MD, PhD, Sture MD, PhD, Pertti K. MD, PhD,